Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting-Reference-Cited by-同舟云学术

Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting

Published:2018-12-07 Issue:6 Volume:54 Page:867-876
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bondanza Attilio, ,Ruggeri Loredana,Noviello Maddalena,Eikema Dirk-Jan,Bonini Chiara,Chabannon Christian^ORCID,van der Werf Steffie,van Biezen Anja,de Wreede Liesbeth C.,Crucitti Lara,Vago Luca,Merluzzi Mara,Massei Maria Speranza,Veelken Hendrik,Koc Yener,Bader Peter,Gruhn Bernd,Locatelli Franco,Ciceri Fabio,Toubert Antoine,Velardi Andrea

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0351-x.pdf

Reference42 articles.

1. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555–62.

2. Aversa F, Reisner Y, Martelli MF. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. Blood Cells Mol Dis. 2004;33:294–302. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15528148.

3. Lown RN, Shaw BE. Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant. 2013;48:210–9. https://doi.org/10.1038/bmt.2012.54

4. Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011;118:282–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21527516.

5. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, et al. Successful engraftment of T-cell-depleted haploidentical “three-loci” incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood. 1994;84:3948–55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7524753.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Vδ2+ T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation;Annals of Hematology;2023-02-10

2. Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment;Blood Reviews;2023-01

3. T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy;Frontiers in Pediatrics;2022-10-14

4. Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment;Frontiers in Oncology;2022-07-15

5. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives;Frontiers in Immunology;2020-09-16